- Home
- SF vs FMS Comparison
SF vs FMS Comparison
Compare SF & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SF | FMS |
|---|---|---|
| Founded | 1890 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 13.5B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | SF | FMS |
|---|---|---|
| Price | $126.93 | $23.54 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 8 | 2 |
| Target Price | ★ $130.00 | $30.00 |
| AVG Volume (30 Days) | ★ 794.0K | 505.7K |
| Earning Date | 01-28-2026 | 11-04-2025 |
| Dividend Yield | 1.44% | ★ 2.42% |
| EPS Growth | 2.14 | ★ 8.62 |
| EPS | ★ 5.66 | 2.86 |
| Revenue | $5,293,276,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $13.43 | $2.12 |
| Revenue Next Year | $11.00 | $2.92 |
| P/E Ratio | $22.53 | ★ $15.99 |
| Revenue Growth | ★ 11.76 | 2.10 |
| 52 Week Low | $73.27 | $22.05 |
| 52 Week High | $133.08 | $30.46 |
Technical Indicators
Market Signals| Indicator | SF | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 58.30 | 45.48 |
| Support Level | $124.67 | $23.43 |
| Resistance Level | $128.75 | $23.88 |
| Average True Range (ATR) | 2.99 | 0.30 |
| MACD | -0.20 | 0.12 |
| Stochastic Oscillator | 55.05 | 70.63 |
Price Performance
Historical ComparisonAbout SF Stifel Financial Corporation
Stifel Financial Corp is a middle-market-focused investment bank that produces more than 90% of its revenue in the United States. Approximately 67% of the company's net revenue is derived from its world-wide wealth management division, which supports over 2,000 financial advisors, with the remainder coming from its institutional securities business. Stifel has a history of being an active acquirer of other financial-services firms.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.